Maximizing Health or Sufficient Capability in Economic Evaluation? A Methodological Experiment of Treatment for Drug Addiction
Ilias Goranitis, Joanna Coast, Ed Day, Alex Copello, Nick Freemantle, Emma Frew
MEDICAL DECISION MAKING | SAGE PUBLICATIONS INC | Published : 2017
Conventional practice within the United Kingdom and beyond is to conduct economic evaluations with "health" as evaluative space and "health maximization" as the decision-making rule. However, there is increasing recognition that this evaluative framework may not always be appropriate, and this is particularly the case within public health and social care contexts. This article presents a methodological case study designed to explore the impact of changing the evaluative space within an economic evaluation from health to capability well-being and the decision-making rule from health maximization to the maximization of sufficient capability. Capability well-being is an evaluative space grounde..View full abstract
Awarded by National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme
Awarded by National Institute for Health Research
Early versions of this article were presented at the Health Economists' Study Group (HESG) meeting hosted by the Academic Unit of Health Economics at the University of Leeds and the 11th international Health Economics Association (iHEA) world congress hosted by the Bocconi University. We would like to acknowledge the feedback from those who participated in both sessions, Prof. Mireia Jofre-Bonet, Prof. Colin Green, and particularly the paper discussant at HESG, Prof. Claire Hulme. We also thank the editor and the 2 anonymous reviewers for their constructive comments and suggestions. Finally, we are grateful to all the participants who took part in the study and to the community drug and alcohol teams located at Leicester (Leicestershire Partnership NHS Trust) and Solihull (Birmingham & Solihull Mental Health NHS Foundation Trust). This work represents independent research funded by the National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme (Grant Reference Number PB-PG-0610-22392), and the views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health.